BioSpace News Archive

According to the report, the global homeopathic product market was valued at US$ 5.6 Bn in 2018 and is projected to expand at a CAGR of ~14% from 2019 to 2027.

COVID-19 refers to a viral infection occurred due to a corona virus named SARS-CoV-2. This virus attacks the respiratory tract of an individual.

The growth of the global cell separation market is estimated to be driven by the growing interest of scientists and biotechnology companies in stem cell research.

A study, funded by the Government of Canada through its COVID-19 Immunity Task Force, has found the risk of staff acquiring SARS-CoV-2, the virus that causes COVID-19, in schools is no greater than their risk of acquiring the virus in day-to-day life in the community.

HumanFirst and the Duke Clinical Research Institute announced the creation of a new Digital Measures Evaluation Center for assessing sensors and other digital measures used in clinical research.

The International Academy of Oral Medicine and Toxicology is raising awareness of research linking cases of arthritis to dental amalgam fillings.

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, announced that the U.S. Food and Drug Administration has accepted for filing the resubmission of its New Drug Application for PEDMARK™ for the prevention of ototoxicity induced by cisplatin chemotherapy in patients one month to < 18 years of age with localized, non-metastatic, solid tumors.

Nevro Corp. announced that data from the SENZA Non-Surgical Refractory Back Pain Randomized Controlled Trial will be presented at the American Society of Interventional Pain Physicians 23rd annual meeting to be held in person from June 24-26, 2021 at the Hilton New Orleans Riverside in New Orleans, Louisiana.

Nordic Nanovector ASA announces encouraging initial results from the LYMRIT 37-05 Phase 1 trial investigating Betalutin® in patients with relapsed/refractory diffuse large B-cell lymphoma not eligible for stem cell transplantation.

European Wellness Biomedical Group has signed a memorandum of understanding with Li Hua Biotechnology to formalize strategic alliance in scientific research and clinical trials development for fertility and immunology in Hunan, China.